Next Generation News and Research

RSS

UTA cancer researcher elected president of the American Society for Photobiology

University of Texas at Arlington cancer researcher Sherri McFarland has been elected president of the American Society for Photobiology (ASP), a national scientific organization dedicated promoting research related to the effects of light on human health and the broader natural world.

20 Sep 2024

FORT-2 trial shows promising results for bladder cancer immunotherapy combination

Findings from the international FORT-2 clinical trial showed that a combination treatment including immunotherapy is safe and tolerable in patients with locally advanced or metastatic bladder cancer.

19 Sep 2024

Phase 1 trial shows safety and efficacy of personalized vaccine for lymphoplasmacytic lymphoma

A team of researchers from City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the U.S., and The University of Texas M.D. Anderson Cancer Center, have reported safety and efficacy results from a Phase 1 trial that featured a personalized vaccine to treat lymphoplasmacytic lymphoma, a rare and slow-growing type of blood cancer, according to a study published recently in Nature Communications.

19 Sep 2024

Study highlights disparities in stroke burden across regions

Although stroke is highly preventable and treatable, there has been a rapid rise in the global stroke burden between 1990 and 2021, due to both population growth and the rise of aging populations worldwide, as well as a substantial increase in people's exposure to environmental and behavioral risk factors.

19 Sep 2024

New biomarkers offer hope for early detection and prevention of Alzheimer's

The failure to diagnose Alzheimer's disease, the most common form of dementia in the elderly, at an early stage of molecular pathology is considered a major reason why treatments fail in clinical trials. Previous research to molecularly diagnose Alzheimer's disease yielded "A/T/N" central biomarkers based on the measurements of proteins, β-amyloid ("A") and tau ("T"), and "N" encompassing neurodegeneration. A/T/N can be measured in brain tissue, by in vivo brain imaging techniques, and by analysis of cerebrospinal fluid and plasma.

18 Sep 2024

Survey reveals significant gaps in global pandemic preparedness

Abbott announced the findings of a new survey; among leading infectious disease experts around the world on the state of pandemic preparedness and found that while most agree that preparation has improved since the COVID-19 pandemic, respondents say significant gaps remain in building surveillance programs to identify emerging pathogens, public health funding and having adequate testing infrastructure capabilities.

18 Sep 2024

New $3.26 million grant launches Undiagnosed Diseases Network site in New York

A new four-year, $3.26 million grant from the National Institute of Neurological Disorders and Stroke (NINDS), a part of the National Institutes of Health (NIH), establishes the first Undiagnosed Diseases Network (UDN) site in the New York metropolitan area.

17 Sep 2024

Huntsman Cancer Institute celebrates 25 years of innovations in cancer research and care

On September 13, 2024, Huntsman Cancer Institute at the University of Utah (the U), the National Cancer Institute-designated cancer center for the Mountain West, celebrates 25 years of groundbreaking cancer research, education, and patient care.

13 Sep 2024

Breakthrough in understanding formaldehyde toxicity during development and aging

AMeD syndrome is a severe genetic condition found in children that present with accelerated aging, global developmental delay and bone marrow failure, among others, progressing to Myelodysplastic Syndrome and Acute Myeloid Leukaemia.

13 Sep 2024

ISM2196: A promising AI-developed WRN inhibitor for advanced metastatic cancers

Insilico Medicine("Insilico"), a clinical-stage generative artificial intelligence (AI)-driven biotechnology company, today announced the nomination of ISM2196, an AI-driven, potential best-in-class small molecule WRN inhibitor targeting advanced metastatic microsatellite instability (MSI) cancers guided by synthetic lethality strategy.

13 Sep 2024

Scripps Research develops breakthrough technique for adding unique amino acids to proteins

It's a dogma taught in every introductory biology class: Proteins are composed of combinations of 20 different amino acids, arranged into diverse sequences like words.

11 Sep 2024

Addressing the challenges of polycystic kidney disease

Polycystic kidney disease (PKD) is an intractable disorder that causes fluid-filled cysts to grow in the kidneys. It is typically seen in adults. As one of the most prevalent hereditary kidney diseases, the autosomal dominant form of PKD is usually caused by mutations in the PKD1 and PKD2 genes.

11 Sep 2024

Natural probiotic present in gut shortly after birth

Findings on neonatal gut microbiota reveal key Bifidobacteria species driving microbiome assembly and their potential in developing personalized probiotics.

10 Sep 2024

Early smoking tied to increased respiratory problems in young adults

People who started smoking under the age of 18 are more likely to experience respiratory symptoms, such as wheezing and phlegm, in their 20s, according to research presented at the European Respiratory Society (ERS) Congress in Vienna, Austria.

9 Sep 2024

Cell-free RNA analysis enhances early detection of pediatric inflammatory conditions

RNA is expelled from cells via cell death or active release, and can then find its way into blood plasma. A Cornell University-led collaboration has developed machine learning models that use these cell-free molecular RNA dregs to diagnose pediatric inflammatory conditions that are difficult to differentiate.

9 Sep 2024

Chinese farmed fur animals found to harbor dozens of novel viruses

Researchers identified 125 virus species in Chinese farmed fur animals, including 36 novel viruses with significant zoonotic potential, emphasizing the need for enhanced surveillance to prevent future pandemics.

9 Sep 2024

NIH awards multi-million grant for groundbreaking organ transplantation research

Researchers at the Terasaki Institute for Biomedical Innovation have been awarded a multi-million grant from the National Institutes of Health (NIH) to advance research in organ transplantation and antibody-mediated rejection.

6 Sep 2024

New DELIVER guidelines aim to accelerate nanomedicine development

They're tiny drug-delivery systems 1000 times smaller than a human hair, but while nanomedicines have long been hailed as the future for treating debilitating and life-threatening diseases, their journey from lab to patient has many challenges.

6 Sep 2024

Auburn University researchers develop AI-driven method to target cancer proteins

Researchers at Auburn University, in collaboration with scientists from the University of Basel and ETH Zurich, have made a groundbreaking advance in the fight against cancer.

5 Sep 2024

Insilico Medicine partners with Inimmune to advance immunotherapeutic discovery

Insilico Medicine("Insilico"), a clinical-stage generative artificial intelligence (AI)-driven biotechnology company, today announced that the company has achieved a groundbreaking collaboration with Inimmune, which will utilize Chemistry42, Insilico's proprietary generative artificial intelligence (AI) technology to accelerate the discovery and development of next-generation immunotherapeutics.

5 Sep 2024

Next Generation News and Research

UTA cancer researcher elected president of the American Society for Photobiology

FORT-2 trial shows promising results for bladder cancer immunotherapy combination

Phase 1 trial shows safety and efficacy of personalized vaccine for lymphoplasmacytic lymphoma

Study highlights disparities in stroke burden across regions

New biomarkers offer hope for early detection and prevention of Alzheimer's

Survey reveals significant gaps in global pandemic preparedness

New $3.26 million grant launches Undiagnosed Diseases Network site in New York

Huntsman Cancer Institute celebrates 25 years of innovations in cancer research and care

Breakthrough in understanding formaldehyde toxicity during development and aging

ISM2196: A promising AI-developed WRN inhibitor for advanced metastatic cancers

Scripps Research develops breakthrough technique for adding unique amino acids to proteins

Addressing the challenges of polycystic kidney disease

Natural probiotic present in gut shortly after birth

Early smoking tied to increased respiratory problems in young adults

Cell-free RNA analysis enhances early detection of pediatric inflammatory conditions

Chinese farmed fur animals found to harbor dozens of novel viruses

NIH awards multi-million grant for groundbreaking organ transplantation research

New DELIVER guidelines aim to accelerate nanomedicine development

Auburn University researchers develop AI-driven method to target cancer proteins

Insilico Medicine partners with Inimmune to advance immunotherapeutic discovery

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News